Form 8-K - Current report:
SEC Accession No. 0001062822-26-000047
Filing Date
2026-03-05
Accepted
2026-03-05 07:01:32
Documents
13
Period of Report
2026-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20260305.htm   iXBRL 8-K 24717
2 EX-99.1 pressreleaseearningsq403-0.htm EX-99.1 76243
  Complete submission text file 0001062822-26-000047.txt   225405

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20260305.xsd EX-101.SCH 1776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20260305_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20260305_pre.xml EX-101.PRE 12504
15 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20260305_htm.xml XML 2738
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 26724154
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)